It is conceivable that HDACi can cause a reversible instability of Myc and a reactivation of epigenetically silenced genes only a few hours after application, as reported by previous studies in Myc-driven cancers [35,40], which could later be reversed and lead to basal Myc expression rates. Here, MYC is linked to cancer.